Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q2 2023 Earnings

9AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.24

-0.16

-0.08

0

Details

Expected EPS

-0.13

Actual EPS

-0.12

Surprise EPS

0.01

Surprise Percent

+7.69%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.12 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.